Dual neutralization of both IL-17A and IL-17F with bimekizumab in patients with psoriasis: results from BE ABLE 1, a 12-week randomized, double-blinded placebo-controlled phase 2b trial
Papp, Kim A., Merola, Joseph F., Gottlieb, Alice B., Griffiths, Christopher E.M., Cross, Nancy, Peterson, Luke, Cioffi, Christopher, Blauvelt, AndrewLanguage:
english
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2018.03.037
Date:
March, 2018
File:
PDF, 2.78 MB
english, 2018